Analysts: more sales Abbvie, relatively high dividend

Abbvie will announce it's last quarter's results tomorrow. Over the current book year the total revenue will be 45,46 billion USD (consensus estimates). This is hugely more than 2019's revenue of 33,27 billion USD.

Historical revenues and results Abbvie plus estimates 2020

The analysts expect for 2020 a net profit of 17,4 billion USD. The majority of the analysts expects for this year a profit per share of 10,32 USD. So the price/earnings-ratio equals 9,47.

Huge dividend Abbvie

Per share the analysts anticipate on a dividend of 4,97 USD per share. Thus the dividend yield equals 5,09 percent. The average dividend yield of the biotech companies is a limited 0,06 percent.

Based on the current number of outstanding shares Abbvie's market capitalization is 144,48 billion USD. The Abbvie stock was the past 12 months quite unstable. Since last July the stock is even 53 percent higher. This year the stock price moved between 63 and 101 dollar.

Historical stock prices Abbvie

Click here for dividend Abbvie. At 1.00 the stock trades 0,31 percent higher at 97,7 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.